Orexigen Therapeutics Inc. | Ownership
Companies that own Orexigen Therapeutics Inc.
The Baupost Group LLC
9,996,116
52.93%
7,269,277
0%
04/13/2018
Bridgeway Capital Management, Inc.
49,100
0.26%
0
0%
12/31/2017
Simplex Trading LLC
5,500
0.03%
-1,800
0%
06/30/2018
Invesco Capital Management LLC
4,655
0.03%
0
0%
09/05/2018
BlackRock Advisors LLC
1,808
0.01%
0
0%
01/31/2018
AdvisorNet Financial, Inc.
1,590
0.01%
0
0%
06/30/2018
Securities America Advisors, Inc.
100
0%
0
0%
06/30/2018
RBC Dominion Securities, Inc.
0
0%
-8
0%
06/30/2018
RBC Dominion Securities, Inc. (Investment Management)
0
0%
-6
0%
06/30/2018
AXA Equitable Funds Management Group LLC
0
0%
-1,308
0%
03/31/2018
| Address |
3344 North Torrey Pines Court
La Jolla California 92037
United States
|
|
Employees
|
- |
| Website |
http://www.orexigen.com |
| Updated |
09/14/2018 |
| Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities includes recruiting personnel, conducting research and development, including clinical trials, raising capital and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. |
